Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. and Sanford Burnham Institute partnered to discover compounds for psychiatric disorders, including Alzheimer's disease (AD)

Sanford-Burnham Medical Research Institute

U.S. / Non-Profit or Major Disease Foundation

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Johnson & Johnson

U.S. / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced